申请人:Japan Tobacco Inc.
公开号:US05151497A1
公开(公告)日:1992-09-29
Novel peptide derivatives of the following formula ##STR1## wherein each symbol is as defined in the specification, pharmaceutically acceptable acid addition salts thereof and analogous copounds thereof. Since the derivatives and their pharmaceutically acceptable acid addition salts of the present invention possess stronger actions on central nervous system (e.g. antagonistic action against hypothermia, locomotor stimulant action, signal reflex stimulant action), they are of use as a therapeutic medicament for central nervous disorders such as impaired consciousness, depression, hypomnesia, the like in association association with schizophrenia, melancholia, senile dementia, sequelae of cerebrovascular disorders, head trauma, epilepsy and spinocerebellar degeneracy.
以下是中文翻译:新型肽衍生物的化学式如下##STR1##其中每个符号如规范中定义的,其药用可接受的酸盐和类似化合物。由于本发明的衍生物及其药用可接受的酸盐具有更强的对中枢神经系统的作用(如对抗低体温的作用、促进运动的作用、刺激反射的作用),因此它们可用作治疗中枢神经系统疾病的药物,如意识障碍、抑郁症、健忘症等,与精神分裂症、忧郁症、老年性痴呆、脑血管疾病后遗症、头部创伤、癫痫和脊髓小脑变性有关。